tiprankstipranks
Advertisement
Advertisement

AGEN Stock Latest News

5 Healthcare Stocks Set to Join the Russell 3000
Market News5 Healthcare Stocks Set to Join the Russell 3000
12d ago
QSI
AGEN
Reiterating Buy on AGEN as Botensilimab/Balstilimab Data Impress in Refractory Melanoma; $23 Price Target Unchanged
PremiumRatings
Reiterating Buy on AGEN as Botensilimab/Balstilimab Data Impress in Refractory Melanoma; $23 Price Target Unchanged
16d ago
AGEN
Agenus Announces Resignation of Principal Accounting Officer
PremiumCompany Announcements
Agenus Announces Resignation of Principal Accounting Officer
22d ago
8K
AGEN
Agenus announces publication of Phase 1b BOT+BAL data
PremiumThe Fly
Agenus announces publication of Phase 1b BOT+BAL data
22d ago
AGEN
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
PremiumRatings
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
26d ago
AGEN
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
PremiumThe FlyMidday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
27d ago
BW
GM
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
Premium
The Fly
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
27d ago
AGEN
Agenus provides 2026 strategic priorities
Premium
The Fly
Agenus provides 2026 strategic priorities
27d ago
AGEN
Agenus announces conclusion of SEC investigation with no enforcement action
PremiumThe Fly
Agenus announces conclusion of SEC investigation with no enforcement action
27d ago
AGEN
AGEN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
AGEN Earnings this Week: How Will it Perform?
29d ago
AGEN
Agenus appoints BAP Pharma as global partner for BOT+BAL access programs
PremiumThe Fly
Agenus appoints BAP Pharma as global partner for BOT+BAL access programs
2M ago
AGEN
Agenus reports Phase 2 results from BOT and BAL with agenT-797
PremiumThe Fly
Agenus reports Phase 2 results from BOT and BAL with agenT-797
2M ago
AGEN
Agenus announces first patient enrolled in Phase 3 BATTMAN trial of BOT+BAL
PremiumThe FlyAgenus announces first patient enrolled in Phase 3 BATTMAN trial of BOT+BAL
2M ago
AGEN
Agenus: Strengthening Bot/Bal Clinical Profile and Capital-Efficient Path to Registration Underpin Positive Rating
Premium
Ratings
Agenus: Strengthening Bot/Bal Clinical Profile and Capital-Efficient Path to Registration Underpin Positive Rating
2M ago
AGEN
Agenus Cervical Cancer Trial Terminated: What RaPiDS Means for AGEN Investors
Premium
Company Announcements
Agenus Cervical Cancer Trial Terminated: What RaPiDS Means for AGEN Investors
2M ago
AGEN
Agenus Securities Class Action Dismissed, Legal Risks Ease
PremiumCompany Announcements
Agenus Securities Class Action Dismissed, Legal Risks Ease
2M ago
8K
AGEN
Agenus: Advancing BATTMAN Phase 3 and Leveraging Zydus Partnership to Strengthen Risk‑Reward Profile and Support Buy Rating
PremiumRatings
Agenus: Advancing BATTMAN Phase 3 and Leveraging Zydus Partnership to Strengthen Risk‑Reward Profile and Support Buy Rating
3M ago
AGEN
Options Volatility and Implied Earnings Moves Today, March 16, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 16, 2026
3M ago
NIU
AGEN
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
3M ago
M
MU
Agenus Inc. (AGEN) Q4 Earnings Cheat Sheet
PremiumPre-EarningsAgenus Inc. (AGEN) Q4 Earnings Cheat Sheet
3M ago
AGEN
Agenus triggers first $20M contingent payment under Zydus Lifesciences pact
Premium
The Fly
Agenus triggers first $20M contingent payment under Zydus Lifesciences pact
3M ago
AGEN
Agenus Forms Major Strategic Collaboration with Zydus Lifesciences
Premium
Company Announcements
Agenus Forms Major Strategic Collaboration with Zydus Lifesciences
5M ago
8K
AGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >